Hims & Hers Health, Inc. HIMS on Tuesday agreed to acquire ZAVA, a European digital health platform. The deal terms were not disclosed.The acquisition consideration will be 100% cash, funded from the company’s balance sheet at closing. The acquisition is expected to close in the second half of 2025.The move will expand Hims & Hers’ footprint in the United Kingdom and officially launch the company into Germany, France, and Ireland, with more markets anticipated soon.In the coming quarters, Hims & Hers will e ...

公司收购与扩张 - 公司宣布收购欧洲数字健康平台ZAVA 此举标志着其全球化扩张的重要一步 将扩大公司在英国的业务并正式进入德国 法国和爱尔兰市场 未来可能拓展更多市场[1] - 收购预计在2025年下半年完成 预计2026年开始产生收益[1] - 公司计划在欧洲推出个性化数字健康服务 涵盖皮肤科 减肥 性健康和心理健康领域 并将提供本地语言服务的英国 德国和法国医疗资源[2] 市场反应与财务表现 - 公告发布后公司股价下跌3 6%[4] - 公司当前市值122 5亿美元 收益率为1 3% 高于行业负收益率 上一季度盈利超出预期66 7%[5] - 过去一年公司股价上涨154 1% 远超行业33 8%和标普500指数11 4%的涨幅[13] 收购战略与行业前景 - 收购ZAVA将利用其现有130万活跃用户和2024年完成的230万次咨询资源 在欧洲建立品牌影响力[6] - 公司计划通过ZAVA平台改善欧洲慢性病(如肥胖和抑郁症)患者的医疗可及性[7] - 全球数字健康市场2024年规模达2885 5亿美元 预计2025-2030年复合增长率22 2% 慢性病远程管理需求和技术进步是主要驱动力[8] 近期其他收购 - 2月收购加州肽设施以加强美国供应链 满足个性化医疗需求[10][11] - 同月收购家庭实验室检测服务商Trybe Labs 扩展家庭抽血检测和全身检测能力 并加速进入低睾酮 围绝经期等新临床领域[12]

It has been about a month since the last earnings report for Hims & Hers Health, Inc. (HIMS) . Shares have added about 10.6% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Hims & Hers Health due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts.How Have Estimates Been M ...

Hims & Hers Health Inc (NYSE:HIMS) stock made waves in premarket trading, after the telehealth firebrand announced the pending acquisition of ZAVA, a European digital health platform. While HIMS has since pivoted lower, this is prime time to check in on telehealth stocks and see which ones investors should be targeting. Hims stock traded as high as $67.35 out of the gate, but was last seen down 2.5% to trade at $55.37. Despite the choppiness, the shares are forming a bullish flag pattern on the charts, and ...

After several months of extreme volatility driven by geopolitical uncertainty and shifting tariff policies, bullish momentum has returned to the market. With tariff policy moderating, economic growth forecasts rebounding, and AI-driven productivity gains continuing to accelerate, investors are once again embracing risk.In this renewed environment, select stocks with strong fundamentals and emergent business models are breaking out. The three companies highlighted here, Hims & Hers Health ((HIMS), AppLovin ( ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...

Hims & Hers Health (NYSE: HIMS) experienced a notable uptick in its stock price following the announcement of its planned acquisition of ZAVA, a prominent European digital health platform. The stock rose 7.77% in pre-market trading on June 3, 2025, reflecting investor optimism about the company’s strategic expansion into Europe. HIMS shares closed at $56.77 on Monday, reflecting a year-to-date increase of approximately 134.78% and a 39.07% gain over the past month. HIMS stock climbs over 7% in pre-market. S ...

Hims & Hers Health, Inc (NYSE: HIMS ) is a telehealth platform offering a wide range of health and wellness services. HIMS connects consumers to healthcare professionals and offers a range of tailored prescriptions, non-prescription products and other services. Over theLW Research is run by a qualified accountant working in the financial services sector mainly in private equity, hedge funds, asset management and venture capital. Since my time working as an accountant I've become extremely well versed at div ...

Hims & Hers (NYSE: HIMS ) is the company of the future. I've already written about HIMS twice on Seeking Alpha ( see here and here ) and over 50 posts on a personalAs a 21-year-old student passionate about stock analysis, I provide in-depth equity research and market insights. With a solid grasp of financial trends, I aim to offer actionable investment ideas and identify growth and value opportunities. Follow me for insightful analyses to navigate the world of investing.Analyst’s Disclosure: I/we have a ben ...